NTRB (Nutriband) Other Financing: $0.12 Mil (TTM As of Apr. 2026)


NTRB Nutriband Inc NTRB
59 GF Score
Price $3.06
GF Value $3.24
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Nutriband Other Financing?

Nutriband NTRB +0.99% 59 Other Financing is $0.12 Mil as of Apr. 2026. GuruFocus rates NTRB with a GF Score™ of 59/100 and a GF Value™ of $3.24 (Fairly Valued). The stock has 4 warning signs investors should review.

Nutriband's Other Financing for the three months ended in Apr. 2026 was $0.00 Mil.

Nutriband's Other Financing for the trailing twelve months (TTM) ended in Apr. 2026 was $0.12 Mil.

Nutriband Other Financing Historical Data

* Premium members only.

The historical data trend for Nutriband's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nutriband Other Financing Chart

Nutriband Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.94 0.30 0.00 0.00 0.12

Nutriband Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.04 0.08 0.00 0.00
NTRB
59GF Score
Nutriband Inc NTRB
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nutriband Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.12 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of $0.12 Mil mean?
Nutriband (NTRB) has a Other Financing of $0.12 Mil as of Apr. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Nutriband and its competitors.
Is Nutriband's Other Financing too high?
Nutriband's current Other Financing is $0.12 Mil. Overall, Nutriband has a GF Score™ of 59/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Nutriband's Other Financing compare to INMB and GRCE?
Nutriband's Other Financing of $0.12 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Biotechnology company?
A good Other Financing depends on the Biotechnology industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Nutriband and its competitors. Nutriband's current Other Financing is $0.12 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nutriband stock overvalued right now?
Based on GuruFocus' analysis, Nutriband (NTRB) is currently considered Fairly Valued. The stock's GF Value™ is $3.24, compared to a current price of $3.06 — trading 5.6% below its estimated fair value. The current Other Financing is $0.12 Mil. Nutriband's overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Nutriband (NTRB), the current Other Financing is $0.12 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nutriband (NTRB) Overvalued in 2026?

Based on GuruFocus' analysis, Nutriband stock appears to be undervalued. The current stock price of $3.06 is trading 5.6% below its estimated GF Value™ of $3.24. GuruFocus considers Nutriband to be Fairly Valued.

Key valuation signals for NTRB:

  • Other Financing: $0.12 Mil
  • GF Value™: $3.24 vs. price of $3.06 (5.6% below fair value)
  • GF Score™: 59/100 with 4 warning signs

No single metric tells the full story. See the NTRB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nutriband Business Description

Address 121 South Orange Avenue, Suite 1500, Orlando, FL, USA, 32801
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. Company operates in two reportable segments namely, Sales of Goods and Services. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
59GF Score

Get the complete analysis for NTRB

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.06
Price
$3.24
GF Value